TC
BBP icon

Telemus Capital’s Virtus Biotech ETF BBP Stock Holding History

Telemus Capital’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,750
Closed -$200K – 356
2021
Q2 		$200K Buy
+3,750
New +$198K 0.01% 330

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SMG
Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return
FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Telemus Capital's BBP Position: Q3 2021 in Review

Telemus Capital sold out of Virtus Biotech ETF (BBP) in Q3 2021, closing a stake of 3,750 shares — an estimated $200K sold.

Telemus Capital first reported a position in BBP in Q2 2021 and held it in 1 quarter. The position peaked at $200K in Q2 2021. 13 funds tracked by Wall St. Rank hold BBP as of Q3 2021.

  • Telemus Capital reported no remaining Virtus Biotech ETF position as of Q3 2021 after selling out during the quarter.
  • Telemus Capital sold 3,750 Virtus Biotech ETF shares in Q3 2021, an estimated $200K.
  • Telemus Capital first reported a position in Virtus Biotech ETF in Q2 2021 and held it in 1 quarter.
  • Telemus Capital's Virtus Biotech ETF position peaked at $200K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2021.

Based on Telemus Capital's 13F filing for Q3 2021, filed 27 Oct 2021.